Atlas Trials

Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)

Clinical trial NCT05560516 · UNKNOWN

Trial details

NCT number
NCT05560516
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
QutenzaDuloxetineChemotherapy-induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Start date
2022-12-01
Primary completion
2024-12-31
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.